Hiroaki Mitsuya

is a Japanese virologist famous for his role in discovery of the anti-HIV drug zidovudine (AZT) as well as other anti-AIDS drugs including didanosine (ddI) and zalcitabine (ddC).

Mitsuya was born in Sasebo, Nagasaki and received his M.D. and Ph.D. from Kumamoto University. He joined the American National Cancer Institute in Bethesda, Maryland, in 1982, working initially on Human T-lymphotropic virus 1 before switching his attention to HIV. His identification of AZT as an anti-HIV drug, as well as the anti-HIV properties of didanosine and zalcitabine, was made in 1985. He was appointed Professor of Hematology, Rheumatology and Clinical Immunology at Kumamoto University Graduate School of Medical And Pharmaceutical Sciences.

In December, 2006, he was awarded the first NIH World AIDS Day Award for his work in developing drugs for AIDS. Mitsuya has been chief of the NCI's Experimental Retrovirology Section since 1991. Provided by Wikipedia
Showing 1 - 7 results of 7 for search 'Hiroaki Mitsuya', query time: 0.02s Refine Results
  1. 1
    Mechanism of Darunavir (DRV)’s High Genetic Barrier to HIV-1 Resistance: A Key V32I Substitution in Protease Rarely Occurs, but Once It Occurs, It Predisposes HIV-1 To Develop DRV Resistance
    Get full text
    article
    Save to List
    Saved in:
  2. 2
    Regulation of the Dimerization and Activity of SARS-CoV-2 Main Protease through Reversible Glutathionylation of Cysteine 300
    Get full text
    article
    Save to List
    Saved in:
  3. 3
    Neutralization of SARS-CoV-2 with IgG from COVID-19-convalescent plasma
    Get full text
    article
    Save to List
    Saved in:
  4. 4
    A novel highly quantitative and reproducible assay for the detection of anti-SARS-CoV-2 IgG and IgM antibodies
    Get full text
    article
    Save to List
    Saved in:
  5. 5
    GRL-0920, an Indole Chloropyridinyl Ester, Completely Blocks SARS-CoV-2 Infection
    Get full text
    article
    Save to List
    Saved in:
  6. 6
    Correlates of neutralizing/SARS-CoV-2-S1-binding antibody response with adverse effects and immune kinetics in BNT162b2-vaccinated individuals
    Get full text
    article
    Save to List
    Saved in:
  7. 7
    A small molecule compound with an indole moiety inhibits the main protease of SARS-CoV-2 and blocks virus replication
    Get full text
    article
    Save to List
    Saved in:
Search Tools: Get RSS Feed — Email this Search — Save Search